Misplaced Pages

This is an old revision of this page, as edited by BogBot (talk | contribs) at 11:58, 3 September 2011 (populated new fields in {{drugbox}} and reordered per bot approval. Report errors and suggestions to User_talk:BogBot). The present address (URL) is a permanent link to this revision, which may differ significantly from the current revision.

Template:Wikify is deprecated. Please use a more specific cleanup template as listed in the documentation.

This article does not cite any sources. Please help improve this article by adding citations to reliable sources. Unsourced material may be challenged and removed. Find sources: "Piprozolin" – news · newspapers · books · scholar · JSTOR (December 2010) (Learn how and when to remove this message)

Piprozolin

Clinical data
ATC code	A05AX01 (WHO)
Identifiers
IUPAC name Ethyl (2Z)-2-(3-ethyl-4-oxo-5-piperidin-1-yl-1,3-thiazolidin-2-ylidene)acetate
CAS Number	17243-64-0
PubChem CID	5911905
ChemSpider	4744588
UNII	7786W0VV8M
CompTox Dashboard (EPA)	DTXSID70864757
ECHA InfoCard	100.037.512
Chemical and physical data
Formula	C14H22N2O3S
Molar mass	298.40 g/mol g·mol
InChI InChI=1S/C14H22N2O3S/c1-3-16-11(10-12(17)19-4-2)20-14(13(16)18)15-8-6-5-7-9-15/h10,14H,3-9H2,1-2H3/b11-10- Key:UAXYBJSAPFTPNB-KHPPLWFESA-N
(verify)

Piprozolin (or piprozoline) is a molecule used in bile therapy.

This drug article relating to the gastrointestinal system is a stub. You can help Misplaced Pages by expanding it.

• v
• t
• e

• Piperidines
• Carboxylate esters
• Thiazolidines
• Lactams
• Gastrointestinal system drug stubs